BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15837193)

  • 1. Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation.
    Squire CJ; Dickson JM; Ivanovic I; Baker EN
    Structure; 2005 Apr; 13(4):541-50. PubMed ID: 15837193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Distinct Cdc2 Pools Regulate Cell Cycle Progression and the DNA Damage Response in the Fission Yeast S.pombe.
    Caspari T; Hilditch V
    PLoS One; 2015; 10(7):e0130748. PubMed ID: 26131711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.
    Knight GL; Turnell AS; Roberts S
    J Virol; 2006 Aug; 80(15):7416-26. PubMed ID: 16840322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory phosphorylation of a mitotic cyclin-dependent kinase regulates the morphogenesis, cell size and virulence of the smut fungus Ustilago maydis.
    Sgarlata C; Pérez-Martín J
    J Cell Sci; 2005 Aug; 118(Pt 16):3607-22. PubMed ID: 16046476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for activation of the titin kinase domain during myofibrillogenesis.
    Mayans O; van der Ven PF; Wilm M; Mues A; Young P; Fürst DO; Wilmanns M; Gautel M
    Nature; 1998 Oct; 395(6705):863-9. PubMed ID: 9804419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3 binding regulates catalytic activity of human Wee1 kinase.
    Rothblum-Oviatt CJ; Ryan CE; Piwnica-Worms H
    Cell Growth Differ; 2001 Dec; 12(12):581-9. PubMed ID: 11751453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.
    Pirruccello M; Sondermann H; Pelton JG; Pellicena P; Hoelz A; Chernoff J; Wemmer DE; Kuriyan J
    J Mol Biol; 2006 Aug; 361(2):312-26. PubMed ID: 16837009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk1-dependent regulation of the mitotic inhibitor Wee1.
    Harvey SL; Charlet A; Haas W; Gygi SP; Kellogg DR
    Cell; 2005 Aug; 122(3):407-20. PubMed ID: 16096060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.
    Smaill JB; Baker EN; Booth RJ; Bridges AJ; Dickson JM; Dobrusin EM; Ivanovic I; Kraker AJ; Lee HH; Lunney EA; Ortwine DF; Palmer BD; Quin J; Squire CJ; Thompson AM; Denny WA
    Eur J Med Chem; 2008 Jun; 43(6):1276-96. PubMed ID: 17869387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
    Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
    Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.
    Watanabe N; Arai H; Iwasaki J; Shiina M; Ogata K; Hunter T; Osada H
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11663-8. PubMed ID: 16085715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the tyrosine kinase domain of the human insulin receptor.
    Hubbard SR; Wei L; Ellis L; Hendrickson WA
    Nature; 1994 Dec 22-29; 372(6508):746-54. PubMed ID: 7997262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination.
    Krajewska M; Heijink AM; Bisselink YJ; Seinstra RI; Silljé HH; de Vries EG; van Vugt MA
    Oncogene; 2013 Jun; 32(24):3001-8. PubMed ID: 22797065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper.
    Wang Z; Liu J; Sudom A; Ayres M; Li S; Wesche H; Powers JP; Walker NP
    Structure; 2006 Dec; 14(12):1835-44. PubMed ID: 17161373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Wee1-like protein kinase to treat cancer.
    Stathis A; Oza A
    Drug News Perspect; 2010 Sep; 23(7):425-9. PubMed ID: 20862394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisite M-phase phosphorylation of Xenopus Wee1A.
    Kim SY; Song EJ; Lee KJ; Ferrell JE
    Mol Cell Biol; 2005 Dec; 25(23):10580-90. PubMed ID: 16287869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
    Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
    J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases.
    Niefind K; Yde CW; Ermakova I; Issinger OG
    J Mol Biol; 2007 Jul; 370(3):427-38. PubMed ID: 17524418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine kinase-substrate interactions.
    Bose R; Holbert MA; Pickin KA; Cole PA
    Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.